Viking Therapeutics, Inc. (VKTX)

Discussion in 'Men's Economics' started by Michael Scally MD, Mar 3, 2018.

  1. Michael Scally MD

    Michael Scally MD Doctor of Medicine

    Viking Therapeutics, Inc. (VKTX)
    Viking Therapeutics

    VKTX : Summary for Viking Therapeutics, Inc. - Yahoo Finance

    [Basically, a LGND spin-off. IMO, ultimate failure. But a possible trade for profit. Be Careful.

    Our lead clinical program is VK5211, a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in Phase 2 development for the treatment of patients recovering from non-elective hip fracture surgery.

    Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
    Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
     
    J DUGIN likes this.
  2. rugerjitsu

    rugerjitsu Member

    Buy now, and sell after earnings bump this week??
     
  3. Michael Scally MD

    Michael Scally MD Doctor of Medicine

    Whoops ...
     
  4. rugerjitsu

    rugerjitsu Member

    Whoops is right! So much manipulation anymore with these types of stocks.